170
Stopping cancer before it starts is the aim of a new prevention-first approach from the Dallas-based Cancer Prevention Initiative (CPI) and Lyda Hill Philanthropies, which committed a $750,000 matching challenge to accelerate the discovery and development of new medicines, such as vaccines and preventive drugs.
“Lyda Hill Philanthropies shares our belief that high-quality science can replace the fear around cancer with understanding and hope,” CPI President Dr. Theodora Ross said in a statement. “Their visionary investment in CPI’s mission brings us closer to a future where cancer prevention leads to longer, healthier lives for many.”
For the full story, check out Dallas Innovates.
